Repair of acute respiratory distress syndrome in COVID-19 by stromal cells (REALIST-COVID Trial): a multicenter, randomized, controlled clinical trial

EA Gorman, J Rynne, HJ Gardiner… - American Journal of …, 2023 - atsjournals.org
Rationale: Mesenchymal stromal cells (MSCs) may modulate inflammation, promoting repair
in coronavirus disease (COVID-19)–related acute respiratory distress syndrome (ARDS) …
被引用次数：12 相关文章

Repair of Acute Respiratory Distress Syndrome in COVID-19 by stromal cells (REALIST-COVID Trial): a multicentre, randomised, controlled trial.

EA Gorman, J Rynne, HJ Gardiner, AJ Rostron… - 2023 - westmid.openrepository.com
Rationale: Mesenchymal stromal cells (MSCs) may modulate inflammation, promoting repair
in COVID-19-related Acute Respiratory Distress Syndrome (ARDS). Objectives: We …

Repair of Acute Respiratory Distress Syndrome in COVID-19 by Stromal Cells (REALIST-COVID Trial): A Multicentre, Randomised, Controlled Trial

EA Gorman, J Rynne, HJ Gardiner… - American Journal of …, 2023 - research.ed.ac.uk
OBJECTIVES: We investigated safety and efficacy of ORBCEL-C (CD362-enriched,
umbilical cord-derived MSCs) in COVID-related ARDS. METHODS: This multicentre …

Repair of Acute Respiratory Distress Syndrome in COVID-19 by Stromal Cells (REALIST-COVID Trial): A Multicentre, Randomised, Controlled Trial.

EA Gorman, J Rynne, HJ Gardiner… - American Journal of …, 2023 - europepmc.org
Mesenchymal stromal cells (MSCs) may modulate inflammation, promoting repair in COVID-
19-related Acute Respiratory Distress Syndrome (ARDS). We investigated safety and …

Repair of acute respiratory distress syndrome in COVID-19 by stromal cells (REALIST-COVID Trial): a multicenter, randomized, controlled clinical trial

EA Gorman, J Rynne, HJ Gardiner… - American Journal of …, 2023 - eprints.soton.ac.uk
Rationale: Mesenchymal stromal cells (MSCs) may modulate inflammation, promoting repair
in coronavirus disease (COVID-19)-related acute respiratory distress syndrome (ARDS) …

[引用][C] Repair of acute respiratory distress syndrome in covid-19 by stromal cells (realist-covid trial) a multicenter, randomized, controlled clinical trial

EA Gorman, J Rynne, HJ Gardiner… - American Journal of …, 2023 - digibuo.uniovi.es
Repair of acute respiratory distress syndrome in covid-19 by stromal cells (realist-covid trial)
a multicenter, randomized, controlled clinical trial RUO Principal Repositorio Institucional de …

Repair of Acute Respiratory Distress Syndrome in COVID-19 by Stromal Cells (REALIST-COVID Trial) A Multicenter, Randomized, Controlled Clinical Trial.

EA Gorman, J Rynne, HJ Gardiner… - American Journal of …, 2023 - search.ebscohost.com
Abstract Rationale: Mesenchymal stromal cells (MSCs) may modulate inflammation,
promoting repair in coronavirus disease (COVID-19)–related acute respiratory distress …

Repair of Acute Respiratory Distress Syndrome in COVID-19 by Stromal Cells (REALIST-COVID Trial): A Multicenter, Randomized, Controlled Clinical Trial

EA Gorman, J Rynne, HJ Gardiner… - … of respiratory and …, 2023 - pubmed.ncbi.nlm.nih.gov
Rationale: Mesenchymal stromal cells (MSCs) may modulate inflammation, promoting repair
in coronavirus disease (COVID-19)-related acute respiratory distress syndrome (ARDS) …

Repair of acute respiratory distress syndrome in COVID-19 by stromal cells (REALIST-COVID Trial): A multicentre, randomised, controlled trial

EA Gorman, J Rynne, HJ Gardiner… - American Journal of …, 2023 - pure.qub.ac.uk
RATIONALE: Mesenchymal stromal cells (MSCs) may modulate inflammation, promoting
repair in COVID-19-related Acute Respiratory Distress Syndrome (ARDS). OBJECTIVES …